Ligand ID: ZD6

Drugbank ID:
Vandetanib
(DB05294)

Indication:
Vandetanib is an antineoplastic kinase inhibitor used to treat symptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease.

LIST OF BINDING INTERFACES for query 'DB05294'
(Click on the 'Details' column to view details on interfaces and similar patterns of amino acids)
Click on the 'View' column to view patterns on the structural viewer)

DrReposER ID	PDB	Ligand	Drug	Organism	Macromolecule	Pfam	Res.	Interface	HETATM	View	Details
2IVU_A_ZD6A3015	2ivu	ZD6	Vandetanib (DB05294)	Homo sapiens	PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET PRECURSOR	PK_Tyr_Ser-Thr	20	LEU A 730 GLY A 731 VAL A 738 ALA A 756 VAL A 757 LYS A 758 GLU A 775 LEU A 779 ILE A 788 LEU A 802 VAL A 804 GLU A 805 TYR A 806 ALA A 807 LYS A 808 TYR A 809 GLY A 810 LEU A 881 SER A 891 ASP A 892	ZD6 A3015		Details
DrReposER ID	PDB	Ligand	Drug	Organism	Macromolecule	Pfam	Res.	Interface	HETATM	View	Details

[["2IVU_A_ZD6A3015","2ivu","ZD6","Vandetanib (DB05294)","Homo sapiens","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET PRECURSOR","PK_Tyr_Ser-Thr",20,"LEU A 730;GLY A 731;VAL A 738;ALA A 756;VAL A 757;LYS A 758;GLU A 775;LEU A 779;ILE A 788;LEU A 802;VAL A 804;GLU A 805;TYR A 806;ALA A 807;LYS A 808;TYR A 809;GLY A 810;LEU A 881;SER A 891;ASP A 892","ZD6 A3015\r"]]